Clinical Trials on Non-Hodgkin's B-cell Lymphoma in Belgium
Total 690 results
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
Debiopharm International SACompletedDiffuse Large B-Cell Lymphoma | B-cell Non-Hodgkin's LymphomaUnited States, Czechia, Bulgaria, Belgium, Hungary, Ukraine, Italy, Poland, Switzerland
-
Novartis PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (B-NHL) | B-cell Acute Lymphoblastic Leukemia (B-ALL)Japan, Italy, Spain, Belgium, Singapore, France, United States, Israel
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkins LymphomaBelgium, Spain, Denmark, Italy, United Kingdom, Israel, United States
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
AbbVieRecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | B Cell MalignanciesUnited States, Israel, Australia, France, United Kingdom, Belgium, Spain
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedDiffuse Large B-Cell LymphomaBelgium
-
Hoffmann-La RocheActive, not recruitingB-cell Non-Hodgkin LymphomaUnited States, Canada, Belgium, Spain, United Kingdom
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
The Lymphoma Academic Research OrganisationKaryopharm Therapeutics IncCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingLymphoma, B-Cell | Non Hodgkin Lymphoma | High-grade B-cell Lymphoma | MYC Translocation | BCL-2 TranslocationNetherlands, Belgium
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
Lymphoma Study AssociationFondation ARCCompletedLymphoma, Large-Cell, DiffuseFrance, Belgium
-
European Organisation for Research and Treatment...Terminated
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large-Cell LymphomaFrance, Belgium
-
Lymphoma Study AssociationFondation ARCTerminatedLymphoma, Large-Cell, DiffuseFrance, Switzerland, Belgium
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
The Lymphoma Academic Research OrganisationPfizerCompletedDiffuse Large B-Cell LymphomaFrance, Belgium
-
Lymphoma Study AssociationCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Lymphoma Study AssociationAmgenTerminatedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
The Lymphoma Academic Research OrganisationJanssen Pharmaceutica N.V., BelgiumTerminatedB-cell LymphomaFrance, Belgium
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Leukemia, Lymphocytic, Chronic, B-CellUnited States, France, Spain, Belgium, Israel
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Belgium, Australia, Denmark, Italy, Spain, France, United Kingdom
-
The Lymphoma Academic Research OrganisationRecruiting
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
BayerActive, not recruitingLymphoma,Non-HodgkinChina, Hong Kong, Spain, Taiwan, Turkey, Japan, Russian Federation, Singapore, France, Austria, Bulgaria, Korea, Republic of, Malaysia, Thailand, United States, Hungary, Italy, Poland, Portugal, Germany, Mexico, Romania, Australia, Uk... and more
-
Lymphoma Study AssociationCompletedLymphoma, Large-Cell, DiffuseUnited States, Australia, Belgium, Czechia, Finland, Germany, Israel, Sweden, Switzerland, United Kingdom
-
Lymphoma Study AssociationCompletedB-Cell LymphomaFrance, Belgium, Switzerland
-
CelgeneCompletedDiffuse B-Cell LymphomaCanada, Spain, Belgium, United States
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupActive, not recruitingPrimary Mediastinal Large B Cell LymphomaFrance, Belgium, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain
-
Boehringer IngelheimCompletedLymphoma, Large B-Cell, DiffuseSpain, Italy, Belgium
-
SanofiCompletedDiffuse Large B-cell LymphomaBelgium, Israel, Spain, Czechia, Turkey, Italy, United States, Poland, United Kingdom
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
BayerCompletedDiffuse, Large B-Cell, LymphomaBelgium, France, Canada, Korea, Republic of, Australia, Germany, United Kingdom, Italy, Denmark, Singapore
-
The Lymphoma Academic Research OrganisationActive, not recruitingB-cell Lymphoma Recurrent | B-Cell Lymphoma RefractoryFrance, Belgium